Atria Investments Inc Acquires 12,906 Shares of Gilead Sciences, Inc. $GILD

robot
Abstract generation in progress

Atria Investments Inc increased its stake in Gilead Sciences, Inc. by 17.2% in the fourth quarter, acquiring an additional 12,906 shares, bringing its total holdings to 87,963 shares valued at approximately $10.8 million. This acquisition follows Gilead’s positive quarterly results, which surpassed analyst expectations for both EPS and revenue, and the company’s announcement of an $0.82 per share quarterly dividend. Analysts maintain a “Moderate Buy” consensus rating for Gilead, with a target price of $157.04.

GILD-2%
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned